EUCTR2006-000165-10-IT进行中（未招募）不适用
Phase II study with gemcitabine/docetaxel fist line in women with metastatic breast cancer. - SF2gem/tax
A.S.L. 2 SAVONA0 个研究点目标入组 70 人开始时间: 2007年1月16日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Metastatic brast cancer adgiuvant treatment with antracicline and treatment with taxans endend least one year before yeras 18 75 ps 2 regular functionality of the liver, hepatic and cardiac informed consent written women fertile age must to use contracceptive to warrant cover 99
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •patient teated before with chemioterapy for metastatic breast cancer previous neoplasm excepts cutaneos and cervix in situ carcinoma pregnansy crerebri metastasy radioterpy on single valuable lesion HERB2/neupos 3 IHC or FISH psichiatrics diseases to obstacle writtent consens only bone metastasis
研究者
相似试验
进行中（未招募）
不适用
Phase II study with gemcitabine/docetaxel first line in women with metastatic breast cancer - SF- 2Gem/taxoncological patients onlyMedDRA version: 6.1Level: PTClassification code 10055113EUCTR2005-006168-71-ITA.S.L. 270
招募中
2 期
Study of gemcitabine docetaxel in synovial sarcoma in relapsed metastatic settingCTRI/2020/02/023612Department of Medical Oncology
招募中
2 期
Phase 2 study of gemcitabine and docetaxel chemotherapy for advanced bone and soft tissue sarcomasadvanced bone and soft tissue sarcomasJPRN-UMIN000031004Kobe University20
招募中
2 期
GD therapy for advanced sarcomasadvanced pretreated bone and soft tissue sarcomasJPRN-jRCTs051180042Hara Hitomi20
进行中（未招募）
1 期
A fase I/II trial with docetaxel and gemcitabine in hormone refractory prostate cancerHormone fractory prostate cancerEUCTR2004-002353-31-DKOrganisation name was not entered60